Shimotsuma, Japan

Kiyotaka Munesada

This inventor holds 4 USPTO granted patents. Top assignees: Pharmacia & Upjohn Company, The Upjohn Co.. Active years: 1995-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiyotaka Munesada. Retrieved from https://idiyas.com/inventor/kiyotaka-munesada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Shimotsuma, JP (1995 - 1999)
  • Shimozuma, JP (1999)

Company Filing History:


Years Active: 1995-1999

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Kiyotaka Munesada

Introduction

Kiyotaka Munesada is a notable inventor based in Shimotsuma, Japan. He has made significant contributions to the field of chemistry, particularly in the development of various pharmaceutical compounds. With a total of four patents to his name, Munesada's work has had a considerable impact on the industry.

Latest Patents

Munesada's latest patents include a process for producing imidazole derivatives and phenyloxazolidinone antimicrobials. These innovations showcase his expertise in creating effective chemical compounds that can be utilized in medical applications.

Career Highlights

Throughout his career, Munesada has worked with prominent companies such as Pharmacia & Upjohn Company and The Upjohn Company. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in pharmaceuticals.

Collaborations

Munesada has collaborated with esteemed colleagues, including Hiroyoshi Yamada and Mikio Taniguchi. These partnerships have fostered a creative environment that has led to the development of innovative solutions in the field.

Conclusion

Kiyotaka Munesada's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new medical treatments and compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…